Inflation Reduction Act

Market Access

Inflation Reduction Act proves positive boost for biosimilar...

For the pharma industry, the IRA has made headlines due to it allowing price negotiations on top-selling treatments.

News

ICER mulls GSK COPD drugs ahead of next Medicare negotiation

The list for the next round of medicines that will be subject to Medicare price negotiations isn’t in yet, but the Institute for Clinical and Economic Review (ICER) reckons a chronic obstru

Market Access

Man listening to Podcast with Alice Valder Curran about Medicare drug pricing negotiations

Medicare drug pricing negotiations: What comes next?

Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the

News

In blink-and-miss-it moment, Harris vows to expand OOP cap

The US Presidential debate barely mentioned pharma topics, but Harris did have one notable sound bite toward the very end of the night.

Market Access

Drug pricing overhaul sparks tension with industry

Up until recently, political rhetoric targeting the pharma industry had been largely all bark and no bite.

News

Vice President Kamala Harris and President Joe Biden in conversation

Biden, Harris 'just getting started' on IRA drug price cuts

In their first joint appearance since Joe Biden withdrew from the Presidential race to be replaced on the Democrat ticket by Kamala Harris, the duo celebrated the long sought-after Medicare